摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(四氢-2H-吡喃-2-基)-4-(4,4,5,5-四甲基-1,3,2-二噁硼烷-2-基)-2H-吲唑 | 1146955-35-2

中文名称
2-(四氢-2H-吡喃-2-基)-4-(4,4,5,5-四甲基-1,3,2-二噁硼烷-2-基)-2H-吲唑
中文别名
——
英文名称
2-(tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole
英文别名
2-(tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole;2-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole
2-(四氢-2H-吡喃-2-基)-4-(4,4,5,5-四甲基-1,3,2-二噁硼烷-2-基)-2H-吲唑化学式
CAS
1146955-35-2
化学式
C18H25BN2O3
mdl
——
分子量
328.219
InChiKey
RSQIEDANVHBVHU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    497.8±35.0 °C(Predicted)
  • 密度:
    1.19±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.03
  • 重原子数:
    24
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.61
  • 拓扑面积:
    45.5
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2934999090
  • 储存条件:
    室温

SDS

SDS:f072609f283aa9791dc08febba66d3e5
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] METHOD FOR MANUFACTURING A BORONIC ACID ESTER COMPOUND<br/>[FR] PROCÉDÉ POUR LA FABRICATION D'UN COMPOSÉ ESTER DE L'ACIDE BORONIQUE
    申请人:SUMITOMO CHEMICAL CO
    公开号:WO2010110782A1
    公开(公告)日:2010-09-30
    The present invention relates to a method for manufacturing a boronic acid ester compound, characterized by reacting an aryl halide compound and a diboron ester compound in the presence of a nitrogen-containing organic base, a nickel catalyst, a phosphine compound and a solvent. According to the manufacturing method of the present invention, even if a nickel catalyst is used as the catalyst, a desired boronic acid ester compound can be obtained in a sufficiently high yield. Furthermore, even if aryl chloride or aryl bromide having relatively low price and low reactivity, was used as the aryl halide compound, a desired boronic acid ester compound can be obtained in a sufficiently high yield.
    本发明涉及一种制造硼酸酯化合物的方法,其特征在于在氮含有机碱、镍催化剂、膦化合物和溶剂的存在下,将芳基卤化物化合物和二硼酯化合物反应。根据本发明的制造方法,即使使用镍催化剂作为催化剂,也可以获得所需的硼酸酯化合物,并且收率足够高。此外,即使使用价格相对较低且反应性较低的芳基氯化物或芳基溴化物作为芳基卤化物化合物,也可以获得所需的硼酸酯化合物,并且收率足够高。
  • METHOD FOR MANUFACTURING A BORONIC ACID ESTER COMPOUND
    申请人:Miki Takashi
    公开号:US20120123122A1
    公开(公告)日:2012-05-17
    The present invention relates to a method for manufacturing a boronic acid ester compound, characterized by reacting an aryl halide compound and a diboron ester compound in the presence of a nitrogen-containing organic base, a nickel catalyst, a phosphine compound and a solvent. According to the manufacturing method of the present invention, even if a nickel catalyst is used as the catalyst, a desired boronic acid ester compound can be obtained in a sufficiently high yield. Furthermore, even if aryl chloride or aryl bromide having relatively low price and low reactivity, was used as the aryl halide compound, a desired boronic acid ester compound can be obtained in a sufficiently high yield.
    本发明涉及一种制备硼酸酯化合物的方法,其特征在于在氮含有机碱、镍催化剂、膦化合物和溶剂的存在下,将芳基卤化物化合物和二硼酯化合物反应。根据本发明的制造方法,即使使用镍催化剂作为催化剂,也可以获得所需的硼酸酯化合物,产率足够高。此外,即使使用价格较低且反应性较低的芳基氯化物或芳基溴化物作为芳基卤化物化合物,也可以获得所需的硼酸酯化合物,产率足够高。
  • A Practical Synthesis of a PI3K Inhibitor under Noncryogenic Conditions via Functionalization of a Lithium Triarylmagnesiate Intermediate
    作者:Qingping Tian、Zhigang Cheng、Herbert M. Yajima、Scott J. Savage、Keena L. Green、Theresa Humphries、Mark E. Reynolds、Srinivasan Babu、Francis Gosselin、David Askin、Isao Kurimoto、Norihiko Hirata、Mitsuhiro Iwasaki、Yasuharu Shimasaki、Takashi Miki
    DOI:10.1021/op3002992
    日期:2013.1.18
    We report a practical synthesis of PI3K inhibitor GDC-0941. The synthesis was achieved using a convergent approach starting from a thienopyrimidine intermediate through a sequence of formylation and reductive amination followed by Suzuki-Miyaura cross-coupling. Metalation of the thienopyrimidine intermediate involving the intermediacy of triarylmagnesiates allowed formylation under noncryogenic conditions
    我们报告了P​​I3K抑制剂GDC-0941的实用合成。使用收敛方法从噻吩并嘧啶中间体开始,通过一系列甲酰化和还原性胺化反应,然后进行Suzuki-Miyaura交叉偶联,实现了合成。噻吩并嘧啶中间体的金属化涉及三芳基镁酸酯的中间体,从而在非低温条件下进行甲酰化以产生相应的醛。我们还研究了通过苯并三唑基-哌嗪底物进行的氨基烷基化,作为还原性胺化途径的替代方法。我们评估了硼化和铃木-宫浦交叉偶联的钯和镍催化过程。最终的脱保护和盐的形成提供了API。
  • Process for making thienopyrimidine compounds
    申请人:Babu Srinivasan
    公开号:US08354528B2
    公开(公告)日:2013-01-15
    The invention provides processes of preparing, separating, and purifying PI3K inhibitor, Formula (I) and (II) compounds, and novel intermediates for preparing Formula (I) and (II) compounds.
    该发明提供了制备、分离和纯化PI3K抑制剂,公式(I)和(II)化合物的过程,以及制备公式(I)和(II)化合物的新型中间体。
  • PROCESS FOR MAKING THIENOPYRIMIDINE COMPOUNDS
    申请人:Genentech, Inc.
    公开号:US20130109852A1
    公开(公告)日:2013-05-02
    The invention provides processes of preparing, separating, and purifying PI3K inhibitor, Formula I and II compounds, and novel intermediates for preparing Formula I and II compounds.
    该发明提供了制备、分离和纯化PI3K抑制剂、化合物I和II的过程,以及制备化合物I和II的新中间体。
查看更多